Business Segments · EBITDA

Medical and Fluid Solutions — EBITDA

Nordson Medical and Fluid Solutions — EBITDA increased by 12.8% to $79.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.5%, from $76.54M to $79.19M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ2 2026May 21, 2026

How to read this metric

Higher EBITDA indicates stronger operational performance and cash flow generation potential for the segment.

Detailed definition

Earnings before interest, taxes, depreciation, and amortization for the Medical and Fluid Solutions segment, providing a...

Peer comparison

The standard benchmark for segment-level operational performance across the industrial and medical technology sectors.

Metric ID: ndsn_segment_medical_and_fluid_solutions_ebitda

Historical Data

12 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q1 '26Q2 '26
Value$61.46M$61.46M$61.46M$61.46M$64.14M$64.14M$64.14M$64.14M$64.33M$76.54M$70.21M$79.19M
QoQ Change+0.0%+0.0%+0.0%+4.4%+0.0%+0.0%+0.0%+0.3%+19.0%-8.3%+12.8%
YoY Change+4.4%+4.4%+4.4%+4.4%+0.3%+19.3%+9.1%+3.5%
Range$61.46M$79.19M
CAGR+9.7%
Avg YoY Growth+6.2%
Median YoY Growth+4.4%

Frequently Asked Questions

What is Nordson's medical and fluid solutions — ebitda?
Nordson (NDSN) reported medical and fluid solutions — ebitda of $79.19M in Q1 2026.
How has Nordson's medical and fluid solutions — ebitda changed year-over-year?
Nordson's medical and fluid solutions — ebitda increased by 3.5% year-over-year, from $76.54M to $79.19M.
What does medical and fluid solutions — ebitda mean?
A measure of the medical segment's core operational profitability before accounting for financing, taxes, and non-cash asset costs.